Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir
2015 ◽
Vol 55
(5)
◽
pp. 605-613
◽
Keyword(s):
2018 ◽
Vol 7
(12)
◽
pp. 829-837
◽
Keyword(s):
1997 ◽
Vol 107
(1-2)
◽
pp. 5-16
◽
2016 ◽
Vol 55
(11)
◽
pp. 1435-1445
◽
2012 ◽
Vol 29
(7)
◽
pp. 1960-1976
◽
Keyword(s):
2009 ◽
Vol 38
(3)
◽
pp. 448-458
◽
Keyword(s):
2014 ◽
Vol 55
(2)
◽
pp. 168-178
◽
Keyword(s):
2014 ◽
Vol 35
(9)
◽
pp. 543-552
◽